urofollitropin


urofollitropin

 [u″ro-fol´ĭ-tro″pin] a preparation of gonadotropins from the urine of postmenopausal women; it contains hormone" >follicle-stimulating hormone and is used in conjunction with gonadotropin" >human chorionic gonadotropin to induce ovulation in the treatment of female infertility and to stimulate multiple oocyte development in ovulatory patients utilizing technologies" >assisted reproductive technologies. Administered by subcutaneous injection.

ur·o·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin), A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins.

Bravelle

A lyophilised formulation of follicle-stimulating hormone purified from the urine of postmenopausal women, which is used to induce ovulation and as part of the regimen for assisted reproductive technologies—e.g., in vitro fertilisation.
Contraindications Bravelle
• High FSH level indicating primary ovarian failure;
• Uncontrolled thyroid and adrenal dysfunction;
• An organic intracranial lesion—especially pituitary tumours;
• Any cause of infertility other than anovulation;
• Abnormal bleeding of undetermined origin;
• Ovarian cysts or enlargement not due to polycystic ovary syndrome;
• Prior hypersensitivity to urofollitropins, purified;
• Pregnancy.

u·ro·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin) A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins